📰 Nasdaq Codx News
Page 2 - Nasdaq Codx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Codx. Real-time updates on events, politics, business and more.
April 1, 2023
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 20.6% from the February 28th total of 1,310,000 shares. Based on an average trading volume of 135,600 shares, the days-to-cover […]
April 1, 2023
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 20.6% from the February 28th total of 1,310,000 shares. Based on an average daily trading volume, of 135,600 shares, the short-interest ratio is […]
November 16, 2022
Co-Diagnostics (NASDAQ:CODX – Get Rating) had its price target lowered by stock analysts at HC Wainwright from $9.00 to $6.00 in a note issued to investors on Monday, The Fly reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 63.04% from the stock’s previous […]
June 16, 2022
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 1,850,000 shares, a drop of 17.8% from the May 15th total of 2,250,000 shares. Based on an average trading volume of 402,100 shares, the days-to-cover ratio is currently 4.6 days. Separately, […]
April 19, 2022
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 1,900,000 shares, a growth of 24.2% from the March 15th total of 1,530,000 shares. Based on an average trading volume of 451,800 shares, the short-interest ratio is presently […]
April 14, 2022
Co-Diagnostics (NASDAQ:CODX – Get Rating) updated its first quarter 2022 earnings guidance on Thursday. The company provided earnings per share guidance of $0.170-$0.200 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.110. The company issued revenue guidance of $21 million-$22 million, compared to the consensus revenue estimate of $21.28 […]
March 30, 2022
Zacks Investment Research upgraded shares of Co-Diagnostics (NASDAQ:CODX – Get Rating) from a hold rating to a buy rating in a report published on Tuesday, Zacks.com reports. They currently have $7.00 price target on the stock. According to Zacks, “Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics […]
March 26, 2022
HC Wainwright restated their buy rating on shares of Co-Diagnostics (NASDAQ:CODX – Get Rating) in a report published on Friday morning, TipRanks reports. The firm currently has a $15.00 target price on the stock. A number of other research firms have also recently commented on CODX. Sidoti began coverage on shares of Co-Diagnostics in a […]
March 25, 2022
Co-Diagnostics (NASDAQ:CODX – Get Rating) issued its quarterly earnings results on Thursday. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.13, Fidelity Earnings reports. Co-Diagnostics had a return on equity of 50.81% and a net margin of 40.11%. During the same quarter last year, the firm […]
November 29, 2021
At the end of the latest market close, Co-Diagnostics Inc. (CODX) was valued at $8.48. In that particular session, Stock kicked-off at the price of $8.95 while reaching the peak value of $9.90 and lowest value recorded on the day was $8.9401. The stock current value is $9.56.Recently in News on Nove